(Q51391212)

English

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

scientific article published on 15 September 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

steatohepatitis

0 references

1 reference

based on heuristic

inferred from title

fatty liver disease

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

2

object named as

Masato Yoneda

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Kazuaki Chayama

12

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

3

object named as

Hideyuki Hyogo

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

author name string

Yoshio Sumida

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Kanji Yamaguchi

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Masafumi Ono

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Hideki Fujii

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Yuichiro Eguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Yasuaki Suzuki

8

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Shunsuke Imai

9

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Kazuyuki Kanemasa

10

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Koji Fujita

11

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Kohichiroh Yasui

13

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Toshiji Saibara

14

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Norifumi Kawada

15

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Kazuma Fujimoto

16

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Yutaka Kohgo

17

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Takeshi Okanoue

18

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)

19

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

publication date

15 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

46

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

257-268

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Liver fibrosis in overweight patients

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Serum ferritin and risk of the metabolic syndrome in U.S. adults

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0305-6

21 January 2018

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic steatohepatitis in Asia-Oceania

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Applicability of BARD score to Japanese patients with NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of hepatic iron in non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/20842510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-010-0305-6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/20842510

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51391212&oldid=1760248407"